The aim of this paper is to confirm the efficacy to reduce incidence of relapses, to increase rates of conservative radical surgery and eventually survival of concomitant neo-adjuvant chemo-radiotherapy.
Methods
From January 1992 to October 1999, 140 stage II (50.7%) and III (49.3%) patients with adenocarcinoma of the rectum were treated with concomitant chemoradiotherapy followed by radical surgery. Treatment consisted of 25 fractions of 180 cGy (5 days per week), for a total dose of 45 Gy on the whole pelvis. Chemotherapy consisted of 5-FU (350 mg/m2) and leucoverin (10 mg/m2) in bolus for 5 days on days 1-5 and 29-33 of radiation. After an interval of 4-6 weeks, all patients were submitted to surgery.
Results
The median follow-up was 48 months (median, 1-97). At 5 years the overall survival was 71.3% and relapse-free survival was 79.4%. The rate of local control was 90%. Twenty-two (15.7%) patients developed distant metastases. All patients underwent surgery: 26 (18.6%) local excision, 79 (56.4%) anterior resection, 33 (23.6%) abdomino-perineal resection, and 2 (1.4%) Hartmann resection. Consequently, 107 cases (75.4%) underwent conservative surgery. At the time of surgery, 34 patients had negative specimens (24.3%), 45 were in stage I (32.2%), 31 in stage II (22.1%), 32 in stage III (21.4%). The incidence of any grade 3 acute toxicity (WHO) was 5% diarrhea, 20% tenesmus and 11.4% myelosuppression.
Conclusions
The results of this study confirm good tolerance, minor surgery-related complications and efficacy of this regimen on local and distant disease control, with a high percentage of sphincter-saving surgery.
ShikeM., WinawerS.J., GreenvaldP.H., BlochA., HillM.J., SwaroopS.V.: Primary prevention of colorectal cancer: the WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Org, 68: 377–385, 1990.
2.
ChiariR.S., TylerD.S., AnscherM.S., Russell, ClaryB.M., HathornJ., SeiglerH.F.: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg, 221: 778–787, 1995.
3.
GrannA., MinskyB.D., CohenA.M., SaltzL., GuillemJ.G., PatyP.B., KelsenD.P., KemenyN., IlsonD., BassJ.: Preliminary results of pre-operative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum, 40: 515–522, 1997.
RichT.A., SkibberJ.M., AjaniJ.A., BuchholzD.J., ClearyK.R., DubrowR.A., LevinB., LynchP.M., MaterissianS.H., RoubeinL.D., OtaD.M.: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys, 32: 1025–1029, 1995.
6.
RichT.A.: Infusional chemoradiation for operable rectal cancer: post-, pre-, or non-operative management?Oncology, 11: 295–315, 1997.
7.
StrykerS.J., KielK.D., RademakerA., ShawJ.M., UjikiG.T., PotichaS.M.: Preoperative “chemoradiation” for stage II and III rectal carcinoma. Arch Surg, 131: 514–519, 1996.
8.
HealdR.J., RyallR.D.: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet, 1: 1479–1482, 1986.
9.
ZaheerS., PembertonJ.H., FaroukR., DozoisR.R., WolffB.G., IlstrupD.: Surgical treatment of adenocarcinoma of the rectum. Ann Surg, 227: 800–811, 1998.
10.
HealdR.J., SmedhR.K., KaldA., SextonR., MoranB.J.: Abdominoperineal excision of the rectum: an endangered operation. Dis Colon Rectum, 40: 747–751, 1997.
11.
Lopez-KostnerF., LaveryI.C., HoolG.R., RybickiL.A., FazioV.W.: Total mesorectal excision is not necessary for cancer of the upper rectum. Surgery, 124: 612–618, 1998.
Kapiteijn E, Marijnen AMM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group:Preoperative radiotherapy combined with total mesorectal excision for respectable rectal cancer. N Engl J Med, 345: 638–646, 2001.
14.
FrykholmG.J., GlimeliusB., PahlmanL.: Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum, 36: 564–572, 1993.
15.
Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer.Medical Research Council Rectal Cancer Working Party. Lancet, 348: 1605–1610, 1996.
16.
Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum.Medical Research Council Rectal Cancer Working Party. Lancet, 348: 1610–1614, 1996.
17.
ArnaudJ.P., NordlingerB., BossetJ.F., BoesG.H., ShamoudT., SchlagP.M., ReneF.: Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of European Organization for Research and Treatment of Cancer. Br J Surg, 84: 352–357, 1997.
18.
FisherB., WolmarkN., RocketteH., RedmondC., DeutschM., WickerhamD.L., FisherE.R., CaplanR., JonesJ., LernerH.: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst, 80: 21–29, 1988.
19.
GèrardA., BuyseM., NordlingerB., LoygueJ., PeneF., KempfP., BossetJ.F., GignouxM., ArnaudJ.P., DesaiveC.: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg, 208: 606–614, 1988.
Swedish Rectal Cancer Trial Group:Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 336: 980–987, 1997.
23.
CoiaL.R., GundersonL.L., HallerD., HoffmanJ., MohiuddinM., TepperJ.E., BerkeyB., OwenJ.B., HanksG.E.: Outcomes of patients receiving radiation for carcinoma of the rectum. Results of the 1988-1989 Patterns of Care Study. Cancer, 86: 1952–1958, 1999.
24.
Habr-GamaA., SantinhoB., de SouzaP.M., RibeiroU., NadalinW., GanslRHSE, SouzaA., CamposF.G., Gama-RodriguesJ.: Low rectal cancer. Impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum, 41: 1087–1096, 1998.
25.
HarmsB.A., StarlingJ.R.: Current status of sphincter preservation in rectal cancer. Oncology, 4: 53–60, 1990.
26.
Kaminsky-ForrettM.C., ConroyT., LuporsiE., PeiffertD., LapeyreM., BoisselP., GuilleminF., BeyP.: Prognostic implication of diwnstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys, 42: 935–941, 1998.
27.
MaghfoorI., WilkesJ., KuvshinoffB., WestgateS., BryerM., PerryM.C., MiedemaB., DollD., OtaD.: Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer. Proc ASCO, 16: 274, 1997.
28.
MohiuddinM., MarksG.: High dose preoperative irradiation for cancer of the rectum, 1976-1988. Int J Radiat Oncol Biol Phys, 20: 37–43, 1991.
29.
NgA.K., RechtA., BusseP.M.: Sphincter preservation therapy for distal rectal carcinoma: a review. Cancer, 79: 671–683, 1997.
30.
RouanetP., FabreJ.M., DuboisJ.B., DravetF., Saint AubertB., PradelJ., YchouM., SolassonC., PujolH.: Conservative surgery for low rectal carcinoma after high-dose radiation: functional and oncologic results. Ann Surg, 221: 67–73, 1995.
31.
WagmanR., MinskyB.D., CohenA.M., GuillemJ.G., PatyP.B.: Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: long-term follow-up. Int J Radiat Oncol Biol Phys, 42: 51–57, 1998.
32.
ValentiniV., CocoC., CelliniN., GenovesiD., MantiniG., BarbaroB., CogliandoloS., MattanaC., Ambesi-ImpiombatoF., TedescoM., CosimelliM.: Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys, 40: 1067–1075, 1998.
33.
WilletC.G.: Organ preservation in anal and rectal cancers. Curr Opinion Oncol, 8: 329–333, 1996.
34.
MinskyB.D., CohenA.M., EnkerW.E., KemenyN., KelsenD.P., RiechmanB., SaltzL., SigurdsonE.R., FrankelJ., WisebergJ.: Combined modality therapy of rectal cancer: decreased acute toxicity with the pre-operative approach. J Clin Oncol, 10: 1218–1224, 1992.
BossetJ.F., MagninV., MaingonP., MantionG., PellisierE.P., MercierM., ChaillardG., HoriotJ.C.: Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys, 2: 323–327, 2000.
38.
NoraA.J., KhooV.S., Abbruzzese, PazdurR., DubrowR., ClearyK.R., AllenP.K., LynchP.M., GloberG., WolfR., RichT.A., SkibberJ.: Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the MD Anderson Cancer Center Experience. Int J Radiat Oncol Biol Phys, 44: 1027–1028, 1999.
39.
MohiuddinM., RegineW.F., JhonW.J., HagiharaP.F., McGrathP.C., KenadyD.E., MarksG.: Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys, 46: 883–888, 2000.
